2024-10-22 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis

**Company Overview:** HCA Healthcare Inc. is one of the largest healthcare providers in the United States, operating a network of hospitals, surgery centers, and other healthcare facilities.

**1. Performance Relative to S&P 500 (VOO):**

* **Cumulative Return:** HCA has generated a cumulative return of 337.77%, significantly outperforming the S&P 500's 136.39%.
* **Outperformance:** The current outperformance is 201.38%,  placing it in the 97.79th percentile of historical relative performance. This suggests HCA has consistently outpaced the market over the past period.

**2. Recent Price Movement:**

* **Closing Price:** $409.35
* **5-Day Moving Average:** $410.27
* **20-Day Moving Average:** $399.59
* **60-Day Moving Average:** $387.56

The stock is currently trading above all three moving averages, indicating a potential upward trend. However, the recent price action is relatively flat, suggesting some consolidation might be underway.

**3. Technical Indicators:**

* **RSI:** 53.53, indicating a neutral market sentiment.
* **PPO:** 0.35, suggesting potential upward momentum.
* **Delta_Previous_Relative_Divergence:** -0.41, indicating a slight decrease in relative outperformance over the past 20 days.
* **Expected Return:** 10.36%, suggesting that HCA may potentially generate higher returns than the S&P 500 over the long term (2 years or more) with a consistent investment approach.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | 17.49 B$ |
| 2024-05-02 | 6.01 | 17.34 B$ |
| 2023-10-26 | 3.98 | 16.21 B$ |
| 2023-08-02 | 4.35 | 15.86 B$ |
| 2024-07-29 | 4.35 | 15.86 B$ |

The most recent earnings report (2024-07-29) shows a positive EPS beat and revenue exceeding expectations. HCA continues to demonstrate consistent growth in both EPS and revenue, highlighting its strong financial performance.

**5. News and Recent Issues:**

* **Recent Market Outlook:** According to FINBOLD, HCA is a "Strong Buy" with a 1-year price target of $473.75.  Analysts expect continued growth driven by factors like an aging population and increasing healthcare demand.
* **Analyst Opinions:** Numerous analysts have a positive outlook on HCA's future performance. They highlight the company's strong market position, operational efficiency, and growth potential.
* **Performance Highlights:** HCA has consistently outperformed its peers and the broader market in recent years. This trend is attributed to its successful expansion strategy and its ability to navigate industry challenges.

**6. Overall Analysis:**

HCA Healthcare Inc. presents a compelling investment opportunity with its impressive historical outperformance, solid financial fundamentals, and positive future outlook.  The stock is currently trading at a neutral level with signs of upward momentum. However, investors should closely monitor future earnings reports and industry trends for potential shifts in market sentiment.

**7. Investment Recommendation:**

Given the positive technical and fundamental factors, HCA appears to be a promising long-term investment opportunity.  However, potential investors should conduct thorough due diligence before making any investment decisions. 

**Disclaimer:** This information is for informational purposes only and should not be considered financial advice. 
